2,300 results match your criteria Hemifacial Spasm

How I do it a microsurgical neurovascular decompression for hemifacial spasm.

Eur Ann Otorhinolaryngol Head Neck Dis 2021 Jun 3. Epub 2021 Jun 3.

Otoneurosurgical Institute of Champagne-Ardenne, Head and Neck Department, Maison Blanche Hospital, Reims University Hospital, Grand Est Region, France; Department of Neurosurgery, Head and Neck Department, Maison Blanche Hospital, Reims University Hospital, Grand Est Region, France.

View Article and Full-Text PDF

Sensory trick effect in craniofacial dystonia as one of the possible impacts of wearing face masks during the COVID-19 pandemic.

Neurol Res Pract 2021 Jun 1;3(1):24. Epub 2021 Jun 1.

Department of Neurology, Paracelsus Medical University - Nuremberg General Hospital, Breslauer Str. 201, 90471, Nürnberg, Germany.

Background: The report of a patient with blepharospasm during the COVID-19 pandemic suggested a potential ameliorating effect of wearing a face mask.

Objective: We prospectively evaluated a possible symptom change through wearing a face mask in all consecutive patients with craniofacial hyperkinesias in our botulinum toxin outpatient treatment cohort.

Methods: Patients with craniofacial hyperkinesia were asked to rate changes of symptoms between - 2 (markedly worsened), - 1 (slightly worsened), 0 (no change), + 1 (slightly improved) and + 2 (markedly improved). Read More

View Article and Full-Text PDF

Microvascular decompression for hemifacial spasm involving the vertebral artery: A modified effective technique using a gelatin sponge with a FuAiLe medical adhesive.

CNS Neurosci Ther 2021 Jul 28;27(7):857-861. Epub 2021 May 28.

Department of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.

Microvascular Decompression for Hemifacial Spasm Involving the Vertebral Artery (VA): A Modified Effective Technique Using a Gelatin Sponge with a FuAiLe Medical Adhesive. (a)The VA pushes the anterior inferior cerebellar artery (AICA) which compressed the root exit zone (REZ) of the facial nerve. (b) The VA was adhered to the petrous dura, and the AICA was decompressed from the REZ by a Teflon pad. Read More

View Article and Full-Text PDF

Association of Thyroid Hypofunction with Clinical Outcomes after Microvascular Decompression for Hemifacial Spasm.

Eur Neurol 2021 May 27:1-7. Epub 2021 May 27.

Department of Neurosurgery, Konkuk University Medical Center, Seoul, Republic of Korea.

Introduction: Data regarding the association between thyroid dysfunction and hemifacial spasm (HFS) are limited. We conducted a single-center, retrospective study to investigate the predictive value of thyroid dysfunction in patients with HFS after microvascular decompression (MVD).

Methods: Between July 2004 and January 2015, 156 patients who were tested for thyroid hormones after MVD for HFS were enrolled in the present study. Read More

View Article and Full-Text PDF

A New Application of Gelatin Sponge in the Treatment of Hemifacial Spasm by Microvascular Decompression: A Technical Note.

J Neurol Surg A Cent Eur Neurosurg 2021 May 19. Epub 2021 May 19.

Department of Neurosurgery, Shanghai Jiaotong University School of Medicine Xinhua Hospital, Shanghai, China.

Objectives:  Microvascular decompression (MVD) for facial nerve remains the highly efficient hemifacial spasm (HFS) treatment. Nonetheless, a variety of cases have poor response to MVD. Using Teflon plus gelatin sponge in MVD seems to be a good solution. Read More

View Article and Full-Text PDF

Sequential Change of Facial Nerve Motor Function after Microvascular Decompression for Hemifacial Spasm: An Electrophysiological Study.

Neurol Med Chir (Tokyo) 2021 May 14. Epub 2021 May 14.

Department of Neurosurgery, Nakamura Memorial Hospital.

Hemifacial spasm (HFS) patients occasionally present with preoperative facial weakness (PFW) or develop delayed facial palsy (DFP) after microvascular decompression (MVD). This study is aimed to evaluate the neurophysiology underlying facial nerve motor dysfunction in HFS patients preoperatively and postoperatively. In all, 54 HFS patients without prior botulinum toxin injection who underwent MVD were retrospectively reviewed. Read More

View Article and Full-Text PDF

Hemifacial Spasm as the Presenting Manifestation of Type 3c Diabetes Mellitus.

Tremor Other Hyperkinet Mov (N Y) 2021 Apr 26;11:14. Epub 2021 Apr 26.

Department of Neurology, University Hospital "12 de Octubre", Madrid, Spain.

Background: Type 3c diabetes mellitus (T3cDM) usually occurs because of a variety of exocrine pancreatic diseases with varying mechanisms, which eventually lead to secondary pancreatic endocrine insufficiency i.e. hyperglycemia. Read More

View Article and Full-Text PDF

Outcome of Injection Botulinum Toxin in Blepharospasm.

Nepal J Ophthalmol 2021 Jan;13(25):40-49

Tilganga Institute of Ophthalmology, Nepal.

Introduction: Blepharospasm is a condition of involuntary spasm of the orbicularis oculi muscle which leads to intermittent or complete closure of the eyelids. Botulinum toxin is the currently recommended first line treatment for such blepharospasm. This study aims to find out the outcome of injection Botulinum toxin Type A in Blepharospasm. Read More

View Article and Full-Text PDF
January 2021

The Microstructure and Reasonable Management of the Arachnoid During the Infrafloccular Approach for Microvascular Decompression of the Facial Nerve.

Turk Neurosurg 2020 Oct 30. Epub 2020 Oct 30.

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Department of Neurosurgery, Shaanxi Province, The People's Republic of China.

Aim: Arachnoid dissection is a basic step during facial nerve microvascular decompression (MVD). However, the literature focusing on the arachnoid microstructure in this region is scarce, and there are different views on how to handle the arachnoid around the cochlea nerve in order to protect the cochlea nerve. To provide a valuable reference for minimal invasion during facial nerve MVD, the arachnoid microstructure during the infrafloccular approach was studied in this paper. Read More

View Article and Full-Text PDF
October 2020

Validation of a new hemifacial spasm grading questionnaire (HFS score) assessing clinical and quality of life parameters.

J Neural Transm (Vienna) 2021 Jun 8;128(6):793-802. Epub 2021 May 8.

Department of Ophthalmology, University of Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Germany.

Validation of the new hemifacial spasm (HFS) questionnaire "HFS score" that captures both clinical (HFS clinical) and health-related quality of life (HRQOL) parameters (HFS subjective) in one tool and comparison with a global HRQOL questionnaire. Cross sectional, prospective validation study including 143 subjects (62 HFS patients and 81 healthy volunteers) from the University Eye Hospital Bonn. Patients were interviewed with the new HFS score and the SF-12 questionnaire prior to and 3 weeks after Botulinum neurotoxin A (BoNT-A) injection. Read More

View Article and Full-Text PDF

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.

Clin Ophthalmol 2021 28;15:1775-1782. Epub 2021 Apr 28.

Biostatistic Excellence Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Purpose: To assess the impact of botulinum toxin type A (BTX-A) on signs and symptoms of dry eye (DE) in affected eye of hemifacial spasm (HFS) patients and to compare the prevalence of DE between affected and non-affected eye in HFS patients.

Patients And Methods: This prospective study included participants with unilateral HFS, who received BTX-A injection as a treatment. The eyes ipsilateral to the spasm side were used as studied eyes and the contralateral eyes were used as controls. Read More

View Article and Full-Text PDF

Arteriovenous Malformation and Hemifacial Spasm: A Rare Presentation.

Ann Indian Acad Neurol 2021 Jan-Feb;24(1):106-107. Epub 2020 Jun 24.

Department of Neurology, Osmania Medical College, Hyderabad, Telangana, India.

View Article and Full-Text PDF

Real-world experience with botulinum toxin A for the treatment of hemifacial spasm: A study of 1138 injections.

Clin Neurol Neurosurg 2021 Apr 2;205:106632. Epub 2021 Apr 2.

Section of Neurology, Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines; Movement Disorders Service and Section of Neurology, Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines; Department of Neurosciences, College of Medicine - Philippine General Hospital, University of the Philippines Manila, Philippines; Movement Disorders Service and Section of Neurology, Institute for Neurosciences, St. Luke's Medical Center, Global City, Philippines. Electronic address:

Background: Hemifacial spasm (HFS) is a chronic, potentially disabling disorder that often requires long-term management with botulinum toxin (BoNT). In a country where healthcare costs limit compliance to medical follow-up and treatment, the study aims to provide a real-world experience on the use of BoNT for HFS among Filipinos.

Methods: We retrospectively collected data from 162 HFS patients who received 1138 botulinum toxin (BoNT) injections from 2006 to 2019 in our movement disorders center in the Philippines. Read More

View Article and Full-Text PDF

Awake CT-guided percutaneous stylomastoid foramen puncture and radiofrequency ablation of facial nerve for treatment of hemifacial spasm.

J Neurosurg 2021 Apr 16:1-7. Epub 2021 Apr 16.

2Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto, California.

Objective: Hemifacial spasm (HFS) is a debilitating neuromuscular disorder with limited treatment options. The current study describes a novel minimally invasive procedure that provided effective and sustained relief for patients with HFS. The authors provide a detailed description of the awake CT-guided percutaneous radiofrequency ablation (RFA) of the facial nerve for treatment of HFS, and they examine its clinical efficacy. Read More

View Article and Full-Text PDF

Quadrigeminal cistern arachnoid cyst as a probable cause of hemifacial spasm.

Radiol Case Rep 2021 Jun 28;16(6):1300-1304. Epub 2021 Mar 28.

Department of Neurological Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan.

Arachnoid cysts arising in the quadrigeminal cistern (ACQCs) are uncommon. A 68-year-old woman presented with an unsteady gait, facial spasm, and cerebellar ataxia. Non-contrast head computed tomography showed a cystic mass centered in the quadrigeminal cistern accompanying ventriculomegaly. Read More

View Article and Full-Text PDF

Experiences on The Administration of Botulinum Toxin in Movement Disorders.

J Transl Int Med 2021 Mar 5;9(1):52-56. Epub 2021 Jan 5.

Kahramanmaraş Sütçü İmam University, School of Medicine, Department of Neurology, Kahramanmaraş, Turkey.

Background And Objectives: Botulinum toxin injection has been used for many years for various indications such as cervical dystonia, blepharospasm, oromandibular dystonia, hemifacial spasm in neurology. Botulinum toxin injections have been made in our clinic for about ten years. We want to report our experiences about botulinum toxin treatment in neurologic disease. Read More

View Article and Full-Text PDF

Hemifacial spasm caused by a tortuous recurrent perforating artery: A case report.

L Li H Zhang

Neurochirurgie 2021 Apr 15. Epub 2021 Apr 15.

Department of Neurosurgery, West China Hospital of Sichuan University, NO. 37 Guoxue Alley, Chengdu, China. Electronic address:

Introduction: When the culprit vessel in hemifacial spasm (HFS) is hard to determine, this is a challenge in microvascular decompression (MVD) surgery. In such a situation, small arteries such as perforators to the brainstem might be suspected. But small arteries are omnipresent near the facial nerve root exit/entry zone (fREZ). Read More

View Article and Full-Text PDF

Prevalence and severity of neurovascular compression in hemifacial spasm patients.

Brain 2021 Apr 11. Epub 2021 Apr 11.

Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Hemifacial spasm is typically caused by vascular compression of the proximal intracranial facial nerve. Although the prevalence of neurovascular compression has been investigated in a cohort of patients with classical trigeminal neuralgia, the prevalence and severity of neurovascular compression has not been well characterized in patients with hemifacial spasm. We aimed to investigate whether presence and severity of neurovascular compression are correlated to the symptomatic side in patients with hemifacial spasm. Read More

View Article and Full-Text PDF

Quality of life after hemifacial spasm surgery: French versions of the HFS-8 and HFS-30 questionnaires.

Eur Ann Otorhinolaryngol Head Neck Dis 2021 Apr 5. Epub 2021 Apr 5.

Service d'oto-rhino-laryngologie, GHU Pitié-Salpêtrière, Sorbonne Université, AP-HP, DMU ChIR, GRC robotique et innovation chirurgicale, Paris, France.

Objectives: The aim of the present study was to assess quality of life before and after surgery for hemifacial spasm, in order to validate two specific quality of life scales translated in French. Surgical results and complications were reported.

Material And Methods: Twenty-three patients with hemifacial spasm treated by microvascular decompression were retrospectively included. Read More

View Article and Full-Text PDF

Qianzheng powder for the treatment of primary Hemifacial spasm: A protocol for systematic reviews and meta-analysis.

Medicine (Baltimore) 2021 Apr;100(14):e25436

Qihuang Outpatient Department of Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Background: Hemifacial spasm (HFS) is a clinical common neurological disease, its main performance for 1 side or 2 sides muscles (the orbicularis oculi muscle, expression, orbicularisoris muscles) recurrent paroxysmal, involuntary twitching, aggravating when excited or nervous, more severe cases of the disease may include difficulty in opening the eyes, crooked corners of the mouth, and twitching noises in the ears, etc.[1] Early manifestations of the disease are intermittent mild convulsions of the orbicularis oculi muscle, and then gradually spread to 1 side of the facial muscles, such as frowning muscles, nasal muscles, buccinalis muscles, etc, especially the most obvious spasms of the oral muscles, which can involve the ipsilateral platysma muscle in severe cases, with each twitch for a few seconds to a few minutes. The disease will affect the quality of life such as speaking, eating, seeing and so on, and even cause psychological effects such as inferiority, anxiety and depression. Read More

View Article and Full-Text PDF

Challenging Microvascular Decompression Surgery for Hemifacial Spasm.

World Neurosurg 2021 Apr 2. Epub 2021 Apr 2.

Department of Neurosurgery, Konkuk University Medical Center, Seoul, Korea. Electronic address:

Objective: Microvascular decompression (MVD) is the most effective treatment for hemifacial spasm (HFS). However, surgical difficulties due to complex anatomy or revision surgery can endanger the functional integrity of the brainstem. We describe surgically challenging cases and provide operative guidance that may be helpful for neurosurgeons who perform MVDs. Read More

View Article and Full-Text PDF

The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.

Toxins (Basel) 2021 03 16;13(3). Epub 2021 Mar 16.

Department of Psychiatry, Chiang Mai University, Chiang Mai 50200, Thailand.

This study aimed to determine the long-term quality of life (QoL) in hemifacial spasm (HFS) patients after treating with Abo-botulinum toxin A (Abo-BTX). The study assessed the disease-specific QoL (hemifacial spasm questionnaire 30 items; HFS 30), the involuntary movements (abnormal involuntary movement scale; AIMS), general health QoL (Medical Outcomes 36-Item Short Form Health Survey; SF-36), and Depression (the Center of Epidemiologic Studies-Depression questionnaire; CES-D). A total of 74 HFS patients were enrolled from 2012 to 2017. Read More

View Article and Full-Text PDF

Botulinum toxin type-A preparations are not the same medications - clinical studies (Part 2).

Neurol Neurochir Pol 2021 2;55(2):141-157. Epub 2021 Apr 2.

9. Department of Neurology, Faculty of Medicine and Health Sciences. Andrzej Frycz Modrzewski Kraków University, ul. Gustawa Herlinga Grudzińskiego 1, 30-705 Kraków, Poland.

The growing number of Botulinum neurotoxin type A (BoNT/A) preparations on the market has resulted in a search for pharmacological, clinical and pharmacoeconomic differences. Patients are occasionally switched from one botulinum toxin formulation to another. The aim of this paper was to review studies that have made direct comparisons of the three major BoNT/A preparations presently on the market: ona-, abo- and incobotulinumtoxinA. Read More

View Article and Full-Text PDF

[Needle-embedding treatment for hemifacial spasm: research progress].

Zhongguo Zhen Jiu 2021 Feb;41(2):233-6

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing 100700, China.

The articles regarding needle-embedding treatment for hemifacial spasm published before September 30, 2019 were searched from SinoMed, Wanfang, CNKI, VIP and PubMed database, and were analyzed and summarized from treatment methods, acupoint selection, stage differentiation and action mechanism. As a result, 45 Chinese articles were obtained. The needle-embedding treatment was divided into intradermal needling and acupoint thread-embedding; the top five acupoints were Sibai (ST 2), Taiyang (EX-HN 5), Dicang (ST 4), Jiache (ST 6) and spasm trigger points. Read More

View Article and Full-Text PDF
February 2021

Life-threatening complications after microvascular decompression procedure: Lessons from a consecutive series of 596 patients.

J Clin Neurosci 2021 Apr 29;86:64-70. Epub 2021 Jan 29.

Department of Neurosurgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China. Electronic address:

The microvascular decompression procedure (MVD) is widely utilized on patients with neurovascular compression syndromes, such as trigeminal neuralgia, hemifacial spasm and glossopharyngeal neuralgia, which have failed medical therapy. However, surgical complications are an ongoing problem. We retrospectively reviewed a total of 596 patients undergoing MVD in the Affiliated Hospital of Qingdao University from January 2008 to December 2018. Read More

View Article and Full-Text PDF

Is MVD the effective treatment for poorly controlled hypertension?

J Clin Neurosci 2021 Apr 25;86:20-25. Epub 2021 Jan 25.

Department of Neurosurgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.

Background: Studies have shown that microvascular decompression (MVD) surgery could improve the clinical symptoms of hemifacial spasm (HFS) and decrease the blood pressure (BP) in patients with refractory hypertension. More positive long-term results are required to establish MVD as a treatment option for high blood pressure (HBP) and to refine the patient selection criteria.

Methods: From October 2015 to September 2018, based on patient selection for cases with both HFS and poorly controlled HBP of nervous origin, MVD surgeries were performed on 12 patients aiming for better BP control. Read More

View Article and Full-Text PDF

Fully endoscopic versus microscopic vascular decompression for hemifacial spasm: a retrospective cohort study.

Acta Neurochir (Wien) 2021 Mar 25. Epub 2021 Mar 25.

Department of Neurosurgery, China-Japan Friendship Hospital, No. 2 Yinghua Dongjie, Hepingli, Chaoyang District, Beijing, China.

Introduction: Microvascular decompression (MVD) is the preferred surgical method for hemifacial spasm (HFS). The purpose of this study was to analyze the effectiveness and safety of fully endoscopic MVD for HFS relative to microscopic MVD.

Material And Methods: The retrospective study was conducted on HFS patients who underwent microscopic or fully endoscopic MVD from January 2018 to March 2019. Read More

View Article and Full-Text PDF

Facial Nerve Schwannoma Extending to Jugular Foramen: A Case Report.

Ear Nose Throat J 2021 Mar 18:1455613211000292. Epub 2021 Mar 18.

Department of Otorhinolaryngology Head and Neck Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China.

Facial nerve schwannoma (FNS) is a benign, slow-growing schwannoma that originates from Schwann cells. Facial nerve schwannoma is the most common tumor of the facial nerve but rare and only accounts for 0.15% to 0. Read More

View Article and Full-Text PDF